Navigation Links
Statins reduce risks for angioplasty patients

Cholesterol-lowering drugs that help prevent heart disease also appear to cut the risk of a heart attack and other complications after angioplasty.// Angioplasty, an alternative to bypass surgery, allows doctors to open clogged coronary arteries without major surgery by inserting a tiny balloon to the narrowest point and inflating the balloon. But 3 of every 5 patients who go through the procedure will suffer a major setback within 4 years. Some patients suffer heart attacks, others need repeat angioplasty or bypass surgery.

A new study, involving 1,456 patients in 12 countries, has found that cholesterol-lowering drugs could reduce the risk of these complications by 30%, compared with patients taking a placebo. The risk reduced by 40% in patients with more than one clogged artery, and by 45% in patients with diabetes. None of the patients had previously taken the drugs, called statins, and all of them had had their first angioplasty within the previous 8 months.

Statins reduce cholesterol by slowing cholesterol production. Several large studies demonstrated that the drugs prevent heart attacks and heart-disease deaths. Cardiologist Robert Harrington of Duke University said the results are anything but surprising. "It's more evident that statins are good for people with heart disease. we must tell patients undergoing angioplasty that we must start you on a statin."
'"/>




Page: 1

Related medicine news :

1. Statins reduce heart attacks
2. Statins Found To Be Helpful For Patients With Arthritis
3. Long-Term Benefits Of Statins Questioned
4. Statins Not Effective In Treating Calcific Aortic Stenosis
5. Statins Gives New Hope for Increased Survival Rate of Heart Failure Patients
6. The Effects of Statins Questioned
7. Statins Taken For Reducing Cholesterol Found To Reduce Death Rate Associated With Heart Attack As Well
8. Study Finds No Link Between Statins And Breast Cancer Risk
9. Statins Reduce Deaths And Strokes After Carotid Surgery
10. Statins reduces cardiovascular risk but no cancer risk.
11. Statins Prescribed To Those Who Are At a Risk Of Developing A Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/7/2016)... (PRWEB) , ... December 07, ... ... Technologies, announced its newest portable bioelectronic medicine device WellnessPro Plus for consumers ... Plus substantially enhances the WellnessPro platform by expanding the treatment modalities available ...
(Date:12/7/2016)... ... ... “Tomorrow Trump Goes To Washington”: a brief but engaging illustration depicting the ... “Tomorrow Trump Goes To Washington” is the creation of published author, Nancy Engestrom, a ... Nancy attributes her patriotic nature to her WWII veteran father. She says, “I ...
(Date:12/7/2016)... NORFOLK, Va. (Dec. 3, 2016) , ... (PRWEB) ... ... the nation’s only patient advocacy nonprofit for individuals impacted by cerebral cavernous angiomas, ... work in New Mexico with a patient engagement program. New Mexico has more ...
(Date:12/7/2016)... ... 2016 , ... NuevaCare, a leading home care agency based in San Mateo ... pages as part of its ambitious website relaunch. As Bay Area clients scramble to ... agencies serving their city. The new site has several key city-specific pages to address ...
(Date:12/6/2016)... ... December 06, 2016 , ... ... collaborate in developing a vaccine against the Middle East Respiratory Syndrome Coronavirus (MERS-CoV). ... available in South Korea for emergency deployment in the event of a future ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)...  Alopexx Oncology, LLC announced data from a Phase ... (immunocytokine) composed of interleukin-2 and a CD20-targeting monoclonal antibody. ... cells as Rituxan and maintains the activities of both ... in tumor targeting, engagement of the immune system, and ... the study (abstract #95954) were presented at the 58 ...
(Date:12/6/2016)... Dec. 6, 2016 Homozygous Familial ... Summary Global Markets Direct,s latest ... Familial Hypercholesterolemia (HoFH) – Pipeline Review, H2 ... Familial Hypercholesterolemia (HoFH) (Metabolic Disorders) pipeline landscape. ... disorder which is caused due to mutation ...
(Date:12/6/2016)... 6, 2016   AlloSource , one of ... skin and soft-tissue allografts for use in surgical ... Manager, for being named to the Board of ... Award by the Commerce Department,s National Institute of ... to process excellence. The Baldrige Award is the ...
Breaking Medicine Technology: